头孢他啶阿维巴坦能治疗医院获得性肺炎吗？ - Suppr

Can ceftolozane-tazobactam treat nosocomial pneumonia?

作者信息

Kalil Andre C, Zavascki Alexandre P

机构信息

Division of Infectious Diseases, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA.

Department of Internal Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil; Infectious Diseases Service, Hospital Moinhos de Vento, Porto Alegre, Brazil; Infectious Diseases Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.

出版信息

Lancet Infect Dis. 2019 Dec;19(12):1266-1267. doi: 10.1016/S1473-3099(19)30523-7. Epub 2019 Sep 25.

DOI:10.1016/S1473-3099(19)30523-7

PMID:31563345

Abstract

摘要

相似文献

Can ceftolozane-tazobactam treat nosocomial pneumonia?

Lancet Infect Dis. 2019 Dec;19(12):1266-1267. doi: 10.1016/S1473-3099(19)30523-7. Epub 2019 Sep 25.

Ceftolozane/tazobactam activity tested against Gram-negative bacterial isolates from hospitalised patients with pneumonia in US and European medical centres (2012).

Int J Antimicrob Agents. 2014 Jun;43(6):533-9. doi: 10.1016/j.ijantimicag.2014.01.032. Epub 2014 Mar 26.

Doripenem for treating nosocomial pneumonia and ventilator-associated pneumonia.

Lancet Infect Dis. 2020 Jan;20(1):20. doi: 10.1016/S1473-3099(19)30693-0.

Doripenem for treating nosocomial pneumonia and ventilator-associated pneumonia - Authors' reply.

Lancet Infect Dis. 2020 Jan;20(1):20-21. doi: 10.1016/S1473-3099(19)30717-0.

Ceftolozane/tazobactam pharmacokinetic/pharmacodynamic-derived dose justification for phase 3 studies in patients with nosocomial pneumonia.

J Clin Pharmacol. 2016 Jan;56(1):56-66. doi: 10.1002/jcph.566. Epub 2015 Aug 25.

Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial.

Ann Intensive Care. 2023 Feb 11;13(1):8. doi: 10.1186/s13613-022-01084-8.

Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI).

Clin Infect Dis. 2015 May 15;60(10):1462-71. doi: 10.1093/cid/civ097. Epub 2015 Feb 10.

Efficacy of ceftolozane/tazobactam, alone and in combination with colistin, against multidrug-resistant Pseudomonas aeruginosa in an in vitro biofilm pharmacodynamic model.

Int J Antimicrob Agents. 2019 May;53(5):612-619. doi: 10.1016/j.ijantimicag.2019.01.010. Epub 2019 Jan 23.

Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae Isolates Collected from Respiratory Tract Specimens of Hospitalized Patients in the United States during 2013 to 2015.

Antimicrob Agents Chemother. 2018 Feb 23;62(3). doi: 10.1128/AAC.02125-17. Print 2018 Mar.

Antibacterial effect of ceftolozane/tazobactam in combination with amikacin against aerobic Gram-negative bacilli studied in an in vitro pharmacokinetic model of infection.

J Antimicrob Chemother. 2018 Sep 1;73(9):2411-2417. doi: 10.1093/jac/dky225.

引用本文的文献

Advances in novel antibiotics to treat multidrug-resistant gram-negative bacterial infections.

Intern Emerg Med. 2021 Nov;16(8):2231-2241. doi: 10.1007/s11739-021-02749-1. Epub 2021 May 6.

New cephalosporins for the treatment of pneumonia in internal medicine wards.

J Thorac Dis. 2020 Jul;12(7):3747-3763. doi: 10.21037/jtd-20-417.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Can ceftolozane-tazobactam treat nosocomial pneumonia?

作者信息

Kalil Andre C, Zavascki Alexandre P

机构信息

Division of Infectious Diseases, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA.

出版信息

Lancet Infect Dis. 2019 Dec;19(12):1266-1267. doi: 10.1016/S1473-3099(19)30523-7. Epub 2019 Sep 25.

DOI:10.1016/S1473-3099(19)30523-7

PMID:31563345

Abstract

摘要

相似文献

Can ceftolozane-tazobactam treat nosocomial pneumonia?

Lancet Infect Dis. 2019 Dec;19(12):1266-1267. doi: 10.1016/S1473-3099(19)30523-7. Epub 2019 Sep 25.

Ceftolozane/tazobactam activity tested against Gram-negative bacterial isolates from hospitalised patients with pneumonia in US and European medical centres (2012).

Int J Antimicrob Agents. 2014 Jun;43(6):533-9. doi: 10.1016/j.ijantimicag.2014.01.032. Epub 2014 Mar 26.

Doripenem for treating nosocomial pneumonia and ventilator-associated pneumonia.

Lancet Infect Dis. 2020 Jan;20(1):20. doi: 10.1016/S1473-3099(19)30693-0.

Doripenem for treating nosocomial pneumonia and ventilator-associated pneumonia - Authors' reply.

Lancet Infect Dis. 2020 Jan;20(1):20-21. doi: 10.1016/S1473-3099(19)30717-0.

Ceftolozane/tazobactam pharmacokinetic/pharmacodynamic-derived dose justification for phase 3 studies in patients with nosocomial pneumonia.

J Clin Pharmacol. 2016 Jan;56(1):56-66. doi: 10.1002/jcph.566. Epub 2015 Aug 25.

Ann Intensive Care. 2023 Feb 11;13(1):8. doi: 10.1186/s13613-022-01084-8.

Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI).

Clin Infect Dis. 2015 May 15;60(10):1462-71. doi: 10.1093/cid/civ097. Epub 2015 Feb 10.

Efficacy of ceftolozane/tazobactam, alone and in combination with colistin, against multidrug-resistant Pseudomonas aeruginosa in an in vitro biofilm pharmacodynamic model.

Int J Antimicrob Agents. 2019 May;53(5):612-619. doi: 10.1016/j.ijantimicag.2019.01.010. Epub 2019 Jan 23.

Antimicrob Agents Chemother. 2018 Feb 23;62(3). doi: 10.1128/AAC.02125-17. Print 2018 Mar.

Antibacterial effect of ceftolozane/tazobactam in combination with amikacin against aerobic Gram-negative bacilli studied in an in vitro pharmacokinetic model of infection.

J Antimicrob Chemother. 2018 Sep 1;73(9):2411-2417. doi: 10.1093/jac/dky225.

引用本文的文献

Advances in novel antibiotics to treat multidrug-resistant gram-negative bacterial infections.

Intern Emerg Med. 2021 Nov;16(8):2231-2241. doi: 10.1007/s11739-021-02749-1. Epub 2021 May 6.

New cephalosporins for the treatment of pneumonia in internal medicine wards.

J Thorac Dis. 2020 Jul;12(7):3747-3763. doi: 10.21037/jtd-20-417.

Can ceftolozane-tazobactam treat nosocomial pneumonia?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Can ceftolozane-tazobactam treat nosocomial pneumonia?

作者信息

机构信息

出版信息

相似文献

引用本文的文献